Oricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
$110MPre-IPO
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation cell therapies for oncology and immunology
Develops next-generation cell therapies for oncology and immunology
Pitching Talon Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room